nafcillin has been researched along with Acute Kidney Injury in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| McKay, L; Spivak, ES; Sutton, JD; Timbrook, TT | 1 |
| Chan, L; Chan-Tompkins, NH; Como, J; Guarascio, AJ | 1 |
| Akcan-Arikan, A; Dutta, A; Galati, M; Kam, C; Moffett, BS; Morris, J | 1 |
| Broadbent, EK; Burrelli, CC; Gold, HS; Hirsch, EB; Mahoney, MV; Margulis, A; McCoy, C; Snyder, GM | 1 |
| Cowgill, LD; Ilkiw, JE; Pascoe, PJ | 1 |
| Lietman, PS; Moore, RD; Smith, CR | 1 |
| Gilbert, DN; Sanford, JP | 1 |
1 review(s) available for nafcillin and Acute Kidney Injury
| Article | Year |
|---|---|
Methicillin: critical appraisal after a decade of experience.
Topics: Acute Kidney Injury; Adult; Aged; Bacteria; Chemical Phenomena; Chemistry; Child; Cloxacillin; Drug Eruptions; Enterococcus faecalis; Humans; Kidney Diseases; Methicillin; Microbial Sensitivity Tests; Middle Aged; Nafcillin; Oxacillin; Penicillin G; Penicillin Resistance; Penicillinase; Protein Binding; Sepsis; Serum Albumin; Staphylococcal Infections | 1970 |
1 trial(s) available for nafcillin and Acute Kidney Injury
| Article | Year |
|---|---|
Studies of risk factors for aminoglycoside nephrotoxicity.
Topics: Acute Kidney Injury; Age Factors; Aminoglycosides; Cefotaxime; Clinical Trials as Topic; Double-Blind Method; Humans; Kidney Diseases; Nafcillin; Probability; Risk; Time Factors; Tobramycin | 1986 |
5 other study(ies) available for nafcillin and Acute Kidney Injury
| Article | Year |
|---|---|
Disproportionality Analysis of Safety with Nafcillin and Oxacillin with the FDA Adverse Event Reporting System (FAERS).
Topics: Acute Kidney Injury; Adverse Drug Reaction Reporting Systems; Anti-Bacterial Agents; Humans; Hypokalemia; Nafcillin; Odds Ratio; Oxacillin; Patient Safety; Staphylococcal Infections; Staphylococcus aureus; United States; United States Food and Drug Administration | 2020 |
Retrospective Analysis of Adverse Drug Events Between Nafcillin Versus Cefazolin for Treatment of Methicillin-Susceptible
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Cefazolin; Female; Humans; Male; Methicillin; Middle Aged; Nafcillin; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2020 |
Vancomycin associated acute kidney injury in pediatric patients.
Topics: Acetazolamide; Acute Kidney Injury; Child; Child, Preschool; Clindamycin; Female; Hospital Mortality; Humans; Infant; Intensive Care Units, Pediatric; Kidney; Logistic Models; Male; Nafcillin; Respiration, Artificial; Retrospective Studies; Risk Factors; Vancomycin | 2018 |
Does the Beta-Lactam Matter? Nafcillin versus Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cefazolin; Creatinine; Female; Humans; Male; Middle Aged; Nafcillin; Retrospective Studies; Severity of Illness Index; Staphylococcus aureus; Tertiary Care Centers; Treatment Outcome | 2018 |
Concerned about renal failure after anesthesia/surgery.
Topics: Acute Kidney Injury; Animals; Dog Diseases; Dogs; Nafcillin; Postoperative Complications; Retrospective Studies | 1994 |